ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
-0.69%
Brent Oil
81.295
-0.80%
Bitcoin
67,464.02
-1.31%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Ginkgo Bioworks Holdings Inc (DNA)

  7. Ginkgo Bioworks Holdings Inc (DNA) News

Ginkgo Bioworks (DNA)

Ginkgo Bioworks Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:DNA
DateTimeSourceHeadlineSymbolCompany
31/05/202416:39Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
30/05/202415:58Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
29/05/202415:45Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
28/05/202415:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
24/05/202415:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
23/05/202415:02Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
22/05/202414:44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
21/05/202416:02Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
20/05/202415:43Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
20/05/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNYSE:DNAGinkgo Bioworks Holdings Inc
17/05/202421:50Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NYSE:DNAGinkgo Bioworks Holdings Inc
17/05/202415:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
17/05/202415:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
17/05/202415:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
16/05/202415:31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
15/05/202418:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
15/05/202412:01PR Newswire (US)Ginkgo Bioworks to Participate in Two Conferences in MayNYSE:DNAGinkgo Bioworks Holdings Inc
14/05/202423:00PR Newswire (US)Sojitz Corporation and Ginkgo Bioworks Announce Plans to Use Synthetic Biology R&D Services to Accelerate Sustainable Manufacturing in JapanNYSE:DNAGinkgo Bioworks Holdings Inc
14/05/202415:48Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
13/05/202421:14Edgar (US Regulatory)Form 8-K - Current reportNYSE:DNAGinkgo Bioworks Holdings Inc
13/05/202421:05PR Newswire (US)Ginkgo Bioworks Receives Continued Listing Standard Notice From NYSENYSE:DNAGinkgo Bioworks Holdings Inc
13/05/202415:50Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
10/05/202415:10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
09/05/202422:16Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NYSE:DNAGinkgo Bioworks Holdings Inc
09/05/202421:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:DNAGinkgo Bioworks Holdings Inc
09/05/202421:02Edgar (US Regulatory)Form 8-K - Current reportNYSE:DNAGinkgo Bioworks Holdings Inc
09/05/202421:01PR Newswire (US)Ginkgo Bioworks Reports First Quarter 2024 Financial ResultsNYSE:DNAGinkgo Bioworks Holdings Inc
09/05/202415:13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
08/05/202415:43Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
07/05/202416:40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
 Showing the most relevant articles for your search:NYSE:DNA

Your Recent History

LSE
IRE
International Real Estate
LSE
CBX
Cellular Goods
ASX
KWRN
Kingwest Resources
ASX
AYT
Austin Metals Lld
AQSE
APOL
Apollon Formularies
ASX
TSK
TASK
ASX
ATHO
Alterity Therapeutics
ASX
CADOA
Caeneus Minerals
ASX
PABNB
Patrys
ASX
ACF
Acrow
ASX
PKON
Peako
ASX
TT4HE
Triton Bond Trust 2020 i...
FX
USDMXN
US Dollar vs MXN
ASX
CCJ
County
NASDAQ
CSIQ
Canadian Solar
ASX
HCSHB
Hyandai Capital Services
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved